PRINCIPAL FINANCIAL GROUP INC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 173 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$50,079
+84.1%
33,165
+5.5%
0.00%
Q4 2023$27,197
-38.2%
31,442
-4.3%
0.00%
Q3 2023$44,002
-25.1%
32,8380.0%0.00%
Q2 2023$58,780
-69.1%
32,838
-32.8%
0.00%
Q1 2023$190,073
-1.6%
48,862
-14.0%
0.00%
Q4 2022$193,137
+77.2%
56,805
+186.5%
0.00%
Q3 2022$109,000
+19.8%
19,827
-2.3%
0.00%
Q2 2022$91,000
-6.2%
20,299
+54.9%
0.00%
Q1 2022$97,000
+24.4%
13,104
+7.7%
0.00%
Q4 2021$78,000
-55.7%
12,172
-59.9%
0.00%
Q3 2021$176,000
-40.7%
30,365
+5.6%
0.00%
Q2 2021$297,000
-11.6%
28,742
-10.0%
0.00%
Q1 2021$336,000
-34.8%
31,953
-4.0%
0.00%
Q4 2020$515,000
+49.7%
33,272
+41.6%
0.00%
Q3 2020$344,000
-27.7%
23,500
-6.5%
0.00%
Q2 2020$476,000
-75.9%
25,129
-60.7%
0.00%
-100.0%
Q1 2014$1,977,000
-22.3%
64,000
-42.3%
0.00%
-20.0%
Q4 2013$2,544,000111,0000.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,827,078$82,205,0004.43%
Palo Alto Investors LP 4,663,324$79,416,0003.21%
Private Capital Advisors, Inc. 473,901$8,071,0002.23%
DOHENY ASSET MANAGEMENT /CA 215,445$3,669,0001.92%
Sandia Holdings, LLC 119,739$2,039,0000.96%
Capital Impact Advisors, LLC 102,006$1,744,0000.60%
Birchview Capital, LP 50,000$852,0000.55%
EMERALD ADVISERS, LLC 694,068$11,820,0000.43%
EMERALD MUTUAL FUND ADVISERS TRUST 647,307$11,024,0000.37%
Schonfeld Strategic Advisors LLC 418,100$7,121,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders